Introduction
gynecological cancer, Cancer
REMISSION, GYNECOLOGIC CANCER, CANCER
As the research community undergoes a “revolutionary” paradigm shift from viewing patients as “subjects” to “experts,” new projects can involve patients in the research lifecycle, from study design to data translation [The present study leverages lived experiences of current and former gynecologic cancer patients to understand the feasibility and compliance concerns of a proposed randomized control trial (RCT), Intermittent Fasting to Restrict Cancer (iFIRE-C), in which gynecological cancer patients in remission or undergoing chemotherapy/radiation treatment will be randomly assigned to eat regularly (control group) or perform intermittent fasting (IF).